Nasal Therapy Improves Symptoms, Inflammation in Patients With Chronic Sinusitis
OPN-375 is currently marketed under the brand name Xhance for the treatment of nasal polyps in patients 18 years of age and older.
Diagnosis & Disease Information
Drug-Device Combo Looks Promising for Chronic Sinusitis
OPN-375 is currently marketed under the brand name Xhance for the treatment of nasal polyps in patients 18 years of age and older.
Narcotic Use Linked to More Complications After Pediatric Sinus Surgery
Multivariate analyses showed that the use of narcotic medications was significantly associated with greater 30-day postoperative complications.
Nasal Swab Test for COVID-19 Risky for Sinus Surgery Patients
Online information needed to warn those with history of sinus, pituitary surgery to avoid nasopharyngeal swab testing, use alternative testing
Sinuva Sinus Implant Launched to Treat Recurrent Nasal Polyps
Sinuva can be implanted during a routine physician visit under local or topical anesthesia.
Antibiotic Treatment Duration for Sinusitis Often Exceeds Recommendations
Duration of outpatient antibiotic therapy for acute sinusitis often exceeds guidelines recommendations.
